Indian equities offer rare discounts for investors. Nippon India Mutual Fund's Equity CIO, Sailesh Raj Bhan, advises accumulating world-cla...

Rising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...

SpaceX's Nasdaq debut shattered expectations, soaring past $2 trillion and becoming the sixth-largest U.S. company. Investors, from institu...

Indian households are reportedly shifting savings back to bank deposits due to weak stock markets and geopolitical concerns. This trend cou...

Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promot...

Global markets are experiencing a tech selloff driven by AI fears, impacting Indian IT stocks with FIIs pulling Rs 60,000 crore. However, s...

In a freewheeling chat, Romesh Pandita, Chairman and Managing Director, Alcobrew Distilleries India, highlights how Indian single malts are...

The Bombay High Court has cancelled the one-time spectrum charges for Bharti Airtel and Vodafone Idea. This decision brings relief of appro...

The Xiaomi 17T strikes a balance between performance and camera capabilities, offering a well-rounded premium smartphone experience. While ...

The 2026 FIFA World Cup in North America will be the largest ever. It will also feature the widest age range of players, from 17-year-old G...

At a time when there are so many headwinds for the markets, it is tough to imagine that things can get better. But sentiment is a fickle th...

Elon Musk's Starlink is poised to disrupt American telecom giants like AT&T and Verizon. Analysts believe Starlink could change how connect...

Vodafone Idea shares have seen significant gains. Citi has upgraded its rating to 'Buy' and set a new target price. This positive outlook i...

Morgan Stanley believes Reliance Industries has entered its fifth monetisation cycle, with artificial intelligence infrastructure and new e...

Wockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Caesarean sections are now the norm in Indian private hospitals, accounting for over half of all births. Eastern and southern states show p...